Novo Nordisk Semaglutide Cut Cardio Risks by 14% in Diabetics: Study
Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Investors Prepare for Major Earnings Week
AbbVie Announces That 9 Canadian Provinces Have Provided Accelerated Public Coverage Of EPKINLY, A Treatment For Adult Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma
Earnings Week Ahead: TSLA, GE, GM, KO, PM, LUV, AAL, VZ, T and More
Tylenol, Listerine Maker Kenvue Under Activist Spotlight With Starboard Value Stake — Overhaul Ahead For The Johnson & Johnson Spinoff?
Activist Investor Starboard Takes Stake in Kenvue - WSJ
Three Events That Shook Health Insurers This Week
Over 60% of Companies That Reported Earnings This Week Beat EPS and Revenue Estimates - Earnings Scorecard
AbbVie Says Latest FDA Approval Expands Botox Use Beyond Face
Tyra Raised to Buy by BofA Ahead of TYRA-300 Data Readout
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug
After Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer Treatment
Stocks Rise, Netflix Soars To Record Highs, Oil Falls Below $70, Gold Miners Rally: What's Driving Markets Friday?
AbbVie Analyst Ratings
Johnson & Johnson Unusual Options Activity
Intuitive Surgical Posts Q3 Earnings Beat, These Analysts Raise Forecasts On DV5 Uptake
Elevance, CVS, UnitedHealth Struggle With Rising Medical Costs After COVID-19 Medicaid Policy Ends
Behind the Scenes of Eli Lilly's Latest Options Trends
Oppenheimer Buy-rated Ideas: BSX, MDT, and One Hold: CYTK